Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome

doi:10.4254/wjh.v9.i19.850

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6791)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

274

WORD

145

HTML

2240

Figures (1-3)

129

Tables (1-4)

127

Sum=2915

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

387

Download

1099

Sum=1486

Publishing Process of This Article

Item

Count

Browse

949

Download

1441

Sum=2390

Jul 8, 2017 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Jul 8, 2017; 9(19): 850-856
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.850

Table 4 Predictors of survival Using Area under Receiver Operating Characteristic

Test	End point	AUROC
Baseline Hepascore alone	Composite endpoint	0.80
	LRD	0.89
	LD	0.75
	HCC	0.87
Baseline Hepascore > 0.75 and Delta Hepascore	Composite endpoint	0.84
	LRD	0.95
	LD	0.77
	HCC	0.93

AUROC: Area under Receiver Operating Characteristic; LRD: Liver related death; LD: Liver decompensation; HCC: Hepatocellular carcinoma.

Citation: Jeffrey AW, Huang Y, de Boer WB, Adams LA, MacQuillan G, Speers D, Joseph J, Jeffrey GP. Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. World J Hepatol 2017; 9(19): 850-856
URL: https://www.wjgnet.com/1948-5182/full/v9/i19/850.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i19.850